Sign In
Buy NEO
$10.14
+0.0200 (+0.198%)
At Close: Jun 03, 2026
NeoGenomics, Inc. (NASDAQ:NEO) Shares Purchased by Exchange Traded Concepts LLC
10:52am, Thursday, 16'th Apr 2020
Exchange Traded Concepts LLC increased its position in shares of NeoGenomics, Inc. (NASDAQ:NEO) by 54.5% during the first quarter, Holdings Channel.com reports. The fund owned 5,083 shares of the medi
NEO Founder Says Blockchain is a Remedy in a Post-Pandemic World
10:40am, Thursday, 16'th Apr 2020
NEO founder Da Hongfei told Blockown 2020 attendees that blockchain technology could be the technological remedy required by a weakened post-pandemic world.
Invitae Gained as Much as 11.8% Today, but It Might Not Last
07:49pm, Tuesday, 14'th Apr 2020
Investors might want to be cautious until the medical genetics company issues first-quarter 2020 operating results.
DealSquare achieves full digitization of private placement process in Canada
02:29pm, Monday, 13'th Apr 2020
DealSquare, the online private placements platform for dealers, investment advisors, investors and capital raisers, today announced the launch of its latest version - DealSquare 2.0. This is a landma
NeoGenomics, Inc. (NASDAQ:NEO) Stock Holdings Trimmed by Cubist Systematic Strategies LLC
08:50am, Monday, 13'th Apr 2020
Cubist Systematic Strategies LLC cut its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO) by 86.8% in the 4th quarter, Holdings Channel reports. The firm owned 13,189 shares of the medical research c
Q3 2020 Earnings Forecast for NeoGenomics, Inc. Issued By SVB Leerink (NASDAQ:NEO)
07:47am, Friday, 10'th Apr 2020
NeoGenomics, Inc. (NASDAQ:NEO) – Investment analysts at SVB Leerink reduced their Q3 2020 earnings per share (EPS) estimates for shares of NeoGenomics in a note issued to investors on Monday, April
Stock Market's Next Move
07:00pm, Thursday, 09'th Apr 2020
The market remains unsettled but is moving higher as it expects good things to happen after the hot spots peak. The impact of the pandemic will keep expanding d
Needham Sticks to Its Buy Rating for NeoGenomics (NEO)
02:23pm, Thursday, 09'th Apr 2020
Needham analyst Stephen Unger maintained a Buy rating on NeoGenomics (NEO) today and set a price target of $33.00. The company's shares closed last
NeoGenomics pulls back FY 2020 guidance amid COVID-19
12:01pm, Thursday, 09'th Apr 2020
Citing COVID-19 disruptions, NeoGenomics (NASDAQ:NEO) is withdrawing its FY 2020 financial guidance. Q1 Revenue is expected to be ~$106M, (+11% Y/Y).Clinical test volume grew ~7% Y/Y in Q1, but was d
NeoGenomics sees Q1 revenue about $106M, consensus $104.42M NEO
11:31am, Thursday, 09'th Apr 2020
NeoGenomics sees Q1 revenue about $106M, consensus $104.42M NEO
Man Group plc Makes New Investment in NeoGenomics, Inc. (NASDAQ:NEO)
11:11am, Thursday, 09'th Apr 2020
Man Group plc acquired a new position in NeoGenomics, Inc. (NASDAQ:NEO) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commissi
NeoGenomics Provides COVID-19 Business Update
11:00am, Thursday, 09'th Apr 2020
MYERS, FL / ACCESSWIRE / April 9, 2020 / NeoGenomics, Inc. (NEO), a leading provider of cancer-focused genetic testing services, provided a business update regarding the impact of the COVID-19 pandemi
Geode Capital Management LLC Acquires 48,681 Shares of NeoGenomics, Inc. (NASDAQ:NEO)
09:46am, Thursday, 09'th Apr 2020
Geode Capital Management LLC boosted its holdings in NeoGenomics, Inc. (NASDAQ:NEO) by 3.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional i
Does NeoGenomics, Inc.’s (NASDAQ:NEO) 32% Earnings Growth Make It An Outperformer?
01:56pm, Wednesday, 08'th Apr 2020
For long term investors, improvement in profitability and outperformance against the industry can be important...
